Autosomal recessive Bardet-Biedl syndrome: First-degree relatives have no predisposition to metabolic and renal disorders

Kidney International

Volumn 76, Issue 2, 2009, Pages 215-223

  Webb, Michael P ^a   Dicks, Elizabeth L ^a   Green, Jane S ^a   Moore, Susan J ^a   Warden, Geoff M ^a   Gamberg, Jane S ^a   Davidson, William S ^b   Young, Terry Lynn ^a   Parfrey, Patrick S ^a,c  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

^b SIMON FRASER UNIVERSITY   (Canada)

^c Health Sciences Centre St John's   (Canada)

Author keywords

Bardet?Biedl syndrome; BBS genes; Diabetes mellitus; Heterozygotes; Obesity; Renal disease

Indexed keywords

ADULT; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BARDET BIEDL SYNDROME; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA DETERMINATION; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE DETECTION; HUMAN; HYPERTENSION; INHERITANCE; KIDNEY DISEASE; METABOLIC DISORDER; OBESITY; PRIORITY JOURNAL; RELATIVE;

AGE OF ONSET; BARDET-BIEDL SYNDROME; COHORT STUDIES; DIABETES MELLITUS; FAMILY HEALTH; FEMALE; FOLLOW-UP STUDIES; GENES, RECESSIVE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; KIDNEY DISEASES; MALE; METABOLIC DISEASES; MUTATION; OBESITY; PEDIGREE;

EID: 67649845823     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.116     Document Type: Article

References (43)

1. Green JS, Parfrey PS, Harnett JD et al. The cardinal manifestations of Bardet-Biedl syndrome, a form of Laurence-Moon-Biedl syndrome. N Engl J Med 1989; 321: 1002-1009.
2. Harnett JD, Green JS, Cramer BC et al. The spectrum of renal disease in Laurence-Moon-Biedl syndrome. N Engl J Med 1988; 319: 615-618.
3. Moore SJ, Green JS, Fan Y et al. Clinical and genetic epidemiology of Bardet-Biedl syndrome in Newfoundland: a 22-year prospective, population-based, cohort study. Am J Med Genet 2005; 132: 352-360.
4. Beales PL, Elcioglu N, Woolf AS et al. New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey. J Med Genet 1999; 36: 437-446.
5. O'Dea D, Parfrey PS, Harnett JD et al. The importance of renal impairment in the natural history of Bardet-Biedl syndrome. Am J Kidney Dis 1996; 27: 776-783.
6. Li JB, Gerdes JM, Haycraft CJ et al. Comparative genomics identifies a flagellar and basal body proteome that includes the BBS5 human disease gene. Cell 2004; 117: 541-552.
7. Mykytyn K, Nishimura D, Searby CC et al. Identification of the gene (BBS1) most commonly involved in Bardet-Biedl Syndrome, a complex human obesity syndrome. Nat Genet 2002; 31: 435-438.
8. Nishimura D, Searby CC, Carmi R et al. Positional cloning of a novel gene on chromosome 16q causing Bardet-Biedl Syndrome. Hum Mol Genet 2001; 10: 865-874.
9. Fan Y, Esmail MA, Ansley SJ et al. Mutations in a member of the RAS superfamily of small GTP binding proteins causes Bardet-Biedl Syndrome. Nat Genet 2004; 36: 389-393.
10. Mykytyn K, Braun T, Carmi R et al. Identification of the gene that, when mutated, causes the human obesity syndrome BBS4. Nat Genet 2001; 28: 188-191.
11. Katsanis N, Beales PL, Woods MO et al. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome. Nat Genet 2000; 26: 67-70.
12. Slavotinek A, Stone EM, Mykytyn K et al. Mutations in MKKS cause Bardet Biedl Syndrome. Nat Genet 2000; 26: 15-16.
13. Badano JL, Ansley SJ, Leitch CC et al. Identification of a novel Bardet-Biedl syndrome protein, BBS7, that shares structural features with BBS1 and BBS2. Am J Hum Genet 2003; 72: 650-658.
14. Ansley S, Badano JL, Blacque OE et al. Basal body dysfunction is a likely cause of pleiotropic Bardet-Biedl syndrome. Nature 2003; 425: 628-633.
15. Nishimura DY, Swiderski RE, Searby CC et al. Comparative genomics and gene expression analysis identifies BBS9, a new Bardet-Biedl syndrome gene. Am J Hum Genet 2005; 77: 1021-1033.
16. Stoetzel C, Laurier V, Davis EE et al. BBS10 encodes a vertebrate-specific chaperonin-like protein and is a major BBS locus. Nat Genet 2006; 38: 521-524.
17. Chiang AP, Beck JS, Yen HJ et al. Homozygosity mapping with SNP arrays identifies TRIM32, an E3 ubiquitin ligase, as a Bardet-Biedl syndrome gene (BBS11). Proc Natl Acad Sci USA 2006; 103: 6287-6292.
18. Stoetzel C, Muller J, Laurier V et al. Identification of a novel BBS gene (BBS12) highlights the major role of a vertebrate-specific branch of chaperonin-related proteins in Bardet-Biedl syndrome. Am J Hum Genet 2007; 80: 1-11.
19. Scuteri A, Sanna S, Chen WM et al. Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 20007; 3: 115.
20. Malecki M, Klupa T. Type 2 diabetes mellitus: from genes to disease. Curr Opin Clin Nutr Metab Care 2005; 57(Suppl): 20-32.
21. Pravenec M, Petretto E. Insight into the genetics of hypertension, a core component of the metabolic syndrome. Curr Opin Clin Nutr Metab Care 2008; 11: 393-397.
22. Freedman B. Genetic factors in common complex renal and cardiovascular diseases. Adv Chronic Kidney Dis 2006; 13: 105-109.
23. O'Dea D, Murphy SW, Hefferton D et al. Higher risk for renal failure in first degree relatives of white patients with end-stage renal disease. A population based study. Am J Kidney Dis 1998; 32: 794-801.
24. Beales PL, Reid HA, Griffiths MH et al. Renal cancer and malformations in relatives of patients with Bardet-Biedl syndrome. Nephrol Dial Transplant 2000; 15: 1977-1985.
25. Croft JB, Swift M. Obesity, hypertension, and renal disease in relatives of Bardet-Biedl syndrome sibs. Am J Med Genet 1990; 36: 37-42.
26. Croft JB, Morrell D, Chase CL et al. Obesity in heterozygous carriers of the gene for the Bardet-Biedl syndrome. Am J Med Genet 1995; 55: 12-15.
27. Qian Q, Hunter LW, Li M et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum Mol Genet 2003; 12: 1875-1880.
28. Parfrey PS, Davidson WS, Green JS. Clinical and genetic epidemiology of inherited renal disease in Newfoundland. Kidney Int 2002; 61: 1925-1934.
29. Bear JC, Nemec TF, Kennedy JC et al. Persistent genetic isolation in outport Newfoundland. Am J Med Genet 1987; 27: 807-830.
30. Service S, DeYoung J, Karayiorgou M et al. Magnitude and distribution of linkage disequilibrium in population isolates and implications for genome-wide association studies. Nat Genet 2006; 38: 556-560.
31. Fan Y, Green JS, Ross AJ et al. Linkage disequilibrium mapping in the Newfoundland population: a re-evaluation of the refinement of the Bardet-Biedl syndrome 1 critical interval. Hum Genet 2005; 116: 62-71.
32. Young TL, Woods MO, Parfrey PS et al. Canadian Bardet-Biedl syndrome family reduces the critical region of BBS3 (3p) and presents with a variable phenotype. Am J Med Genet 1998; 78: 461-467.
33. Young TL, Woods MO, Parfrey PS et al. A founder effect in the Newfoundland population reduces the Bardet-Biedl syndrome I (BBS1) interval to 1cM. Am J Hum Genet 1999; 65: 1680-1687.
34. Woods MO, Young TL, Parfrey PS et al. Genetic heterogeneity of Bardet-Biedl syndrome in a distinct Canadian population: evidence for a fifth locus. Genomics 1999; 55: 2-9.
35. Fan Y, Rahman P, Peddle L et al. Bardet-Biedl syndrome 1 genotype and obesity in the Newfoundland population. Int J Obes Relat Metab Disord 2004; 28: 680-684.
36. Praetorius HA, Spring KR. The renal cell primary cilium functions as a flow sensor. Curr Opin Nephrol Hypertens 2003; 12: 517-520.
37. Pan J, Wang Q, Snell WJ. Cilium-generated signaling and cilia-related disorders. Lab Invest 2005; 85: 452-463.
38. Praetorius HA, Spring KR. A physiological view of the primary cilium. Ann Rev Physiol 2004; 67: 515-529.
39. Davenport JR, Yoder BK. An incredible decade for the primary cilium: A look at a once forgotten organella. Am J Physiol Renal Physiol 2005; 289: F1159-F1169.
40. Hearn T, Spalluto C, Phillips VJ et al. Subcellular localization of ALMS1 supports involvement of centrosome and basal body dysfunction in the pathogenesis of obesity, insulin resistance, and type 2 diabetes. Diabetes 2005; 54: 1581-1587.
41. Stepanyan Z, Kocharyan A, Pyrski M et al. Leptin -target neurones of the rat hypothalamus express somatostatin receptors. J Neuroendocrinol 2003; 15: 822-830.
42. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
43. Stevens LA, Coresh J, Feldman HI et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007; 18: 2749-2757.